Abstract 3077: Preclinical studies of SR-8314, a highly selective ENPP1 inhibitor and an activator of STING pathway
Alexis Weston(Translational Genomics Research Institute), Sunil Sharma(Translational Genomics Research Institute), Hariprasad Vankayalapti(Translational Genomics Research Institute), Haiyong Han(Translational Genomics Research Institute), Mohan R. Kaadige(Translational Genomics Research Institute), Trason Thode(Translational Genomics Research Institute), Sherin Daniel(Translational Genomics Research Institute), Raffaella Soldi(Banner Health), Rubén M. Muñoz(Translational Genomics Research Institute)
Cited by 19
Related Papers
Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells
|PLoS ONE|2016|89
Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells
|PLoS ONE|2012|85